Understanding Cholesterol Guidelines and Implementing Non-statins in High-Risk Populations: Paired Conversations and Case Vignettes

To participate in this activity, please:

Log in Sign Up

An interprofessional faculty of primary care and specialty clinicians discuss real-world issues in managing patients with complex and challenging dyslipidemia, including elevated lipoprotein a (Lp(a)). Several paired conversations serve as the foundation for discussions related to recent cholesterol guidelines, patient risk stratification, and recommended goals for patients at risk of atherosclerotic cardiovascular disease. Two case vignettes provide the basis for robust discussion among the faculty, which centers around clinical decision-making and the roles, benefits, and limitations of approved and investigational pharmacologic treatment options. The 1.5-hour program format fosters critical thinking and application of key concepts to patient cases, enabling participants to advance their clinical practice.

The conversations are also available as a podcast: You may listen here

Course Credit:

1.50 ACPE Contact Hours
1.50 AMA PRA Category 1 CreditsTM
1.50 ANCC Contact Hours
1.50 CA-BRN Contact Hours

Dates:

Opens: 2023-12-29
Closes: 2024-12-29

Target Audience:

This activity was developed for cardiologists, lipidologists, internal medicine specialists, primary care physicians, nurse practitioners, physician associates/assistants, pharmacists and other clinicians who have a role in the diagnosis, treatment, and monitoring of patients with hyperlipidemia.

This activity is supported by an independent educational grant from Novartis Pharmaceuticals.

Accreditation Information

    Presenting Faculty

  • John E. Anderson, MD

    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

  • James M. Backes, PharmD

    Professor
    Associate Dean for Clinical and Medical Center Affairs
    Assistant Director Atherosclerosis and LDL-Apheresis Center
    School of Pharmacy
    Kansas City, Kansas

  • Deepak L. Bhatt, MD, MPH

    Director, Mount Sinai Heart and the Cardiovascular Institute
    Dr. Valentin Fuster Professor of Cardiovascular Medicine
    Icahn School of Medicine
    Mount Sinai Health System
    New York, New York

  • Seth S. Martin, MD

    Director of the Advanced Lipid Disorders Program and Digital Health Lab
    Ciccarone Center for the Prevention of Cardiovascular Disease
    Professor of Medicine
    Johns Hopkins
    Baltimore, Maryland

  • Colleen Walsh-Irwin, DNP

    Associate Director
    Evidence-Based Practice at Department of Veterans Affairs
    E. Northport, New York